Literature DB >> 26339383

Comparison of structural genetics of non-schistosoma-associated squamous cell carcinoma of the urinary bladder.

Marina Molitor1, Kerstin Junker2, Elke Eltze3, Marieta Toma4, Stefan Denzinger5, Sabine Siegert6, Ruth Knuechel1, Nadine T Gaisa1.   

Abstract

Little is known about genetic changes in squamous differentiation of non-schistosomiasis-associated bladder cancer. Therefore, we investigated pure squamous cell carcinomas (SqCC), squamous parts of mixed urothelial carcinomas with squamous differentiation (MIX) and mere urothelial cancers (UC) for structural genetic differences. Tissue microarray slides (n = 29 SqCC, n = 35 MIX and n = 23 UC) were analyzed by ZytoLight SPEC p16/CEN3/7/17 Quadruple Color Probe fluorescence-in-situ-hybridization (FISH) and DNA was investigated by comparative genomic hybridization (CGH) (n = 35 SqCCs, n = 40 MIX and n = 36 UC). By FISH the mean number of polysomic cells was lowest in SqCC (CEN3 P = 0.0498, CEN17 P = 0.0009). A slight tendency of lower copy numbers of chromosomes 3, 7 and 17 and higher numbers of the p16-locus in SqCC (P = 0.45) indicated less aneuploid tumor cells in SqCC compared to MIX and UC. In CGH SqCC showed the lowest mean number of aberrations per tumor (SqCC 5.37 changes, MIX 6.75 and UC 7.64; P = 0.1754). Significant differences between the three groups were found for loss of chromosome 3p (P = 0.004), 6q (P = 0.028), 11p (P = 0.024) and gains of 5p (P = 0.020). Loss of 3p was more frequent in SqCC (51.4%) than in MIX (37.5%) or UC (13.9%). To conclude, SqCCs show less polysomy and genetic alterations than MIX and UC. Loss of 3p is more frequent in SqCC but there are no absolute specific alterations for each tumor group. Squamous parts of mixed tumors show similar alterations than UC and should be considered as further development of UC, while pure SqCC seem to be a separate tumor group.

Entities:  

Keywords:  Bladder cancer; CGH; FISH; squamous cell carcinoma; urothelial carcinoma; urothelial carcinoma with squamous differentiation

Mesh:

Substances:

Year:  2015        PMID: 26339383      PMCID: PMC4555711     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

1.  Genomic imbalances in esophageal squamous cell carcinoma identified by molecular cytogenetic techniques.

Authors:  Marilanda Ferreira Bellini; Ana Elizabete Silva; Marileila Varella-Garcia
Journal:  Genet Mol Biol       Date:  2010-06-01       Impact factor: 1.771

2.  Molecular cytogenetics in childhood leukemia.

Authors:  Christine J Harrison; Helena Kempski; David W Hammond; Lyndal Kearney
Journal:  Methods Mol Med       Date:  2004

Review 3.  Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management.

Authors:  Medhat El-Sebaie; Mohamed Saad Zaghloul; Grahame Howard; Alaa Mokhtar
Journal:  Int J Clin Oncol       Date:  2005-02       Impact factor: 3.402

4.  Chromosomal abnormalities in two bladder carcinomas with secondary squamous cell differentiation.

Authors:  I Fadl-Elmula; L Gorunova; R Lundgren; N Mandahl; N Forsby; F Mitelman; S Heim
Journal:  Cancer Genet Cytogenet       Date:  1998-04-15

Review 5.  Divergent differentiation in urothelial carcinoma and other bladder cancer subtypes with selected mimics.

Authors:  J H Shanks; K A Iczkowski
Journal:  Histopathology       Date:  2008-10-30       Impact factor: 5.087

6.  Comparative genomic hybridization analysis of genetic aberrations associated with development of esophageal squamous cell carcinoma in Henan, China.

Authors:  Yan-Ru Qin; Li-Dong Wang; Zong-Min Fan; Dora Kwong; Xin-Yuan Guan
Journal:  World J Gastroenterol       Date:  2008-03-28       Impact factor: 5.742

7.  CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer.

Authors:  Marina I Gutiérrez; Abdul K Siraj; Hussein Khaled; Natalie Koon; Wa'el El-Rifai; Kishor Bhatia
Journal:  Mod Pathol       Date:  2004-10       Impact factor: 7.842

8.  Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5"'-P1,P3-triphosphate hydrolase.

Authors:  L D Barnes; P N Garrison; Z Siprashvili; A Guranowski; A K Robinson; S W Ingram; C M Croce; M Ohta; K Huebner
Journal:  Biochemistry       Date:  1996-09-10       Impact factor: 3.162

9.  Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases.

Authors:  Nikolaj Lagwinski; Anil Thomas; Andrew J Stephenson; Steven Campbell; Aaron P Hoschar; Ehab El-Gabry; Robert Dreicer; Donna E Hansel
Journal:  Am J Surg Pathol       Date:  2007-12       Impact factor: 6.394

10.  Nonbilharzial squamous cell carcinoma and transitional cell carcinoma with squamous differentiation of the lower and upper urinary tract.

Authors:  Steffen Rausch; Rainer Hofmann; Rolf von Knobloch
Journal:  Urol Ann       Date:  2012-01
View more
  6 in total

Review 1.  Genomic Subtyping in Bladder Cancer.

Authors:  Tuomas Jalanko; Joep J de Jong; Ewan A Gibb; Roland Seiler; Peter C Black
Journal:  Curr Urol Rep       Date:  2020-03-13       Impact factor: 3.092

Review 2.  Molecular and histopathology directed therapy for advanced bladder cancer.

Authors:  Constantine Alifrangis; Ursula McGovern; Alex Freeman; Thomas Powles; Mark Linch
Journal:  Nat Rev Urol       Date:  2019-07-09       Impact factor: 14.432

3.  The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells.

Authors:  Michael Rose; Erik Noetzel; Jennifer Kistermann; Julian Eschenbruch; Sandra Rushrush; Lin Gan; Ruth Knüchel; Nadine T Gaisa; Edgar Dahl
Journal:  Cells       Date:  2021-04-28       Impact factor: 6.600

4.  Expression and prognostic value of PD-L1 in non-schistosoma-associated urinary bladder squamous cell carcinoma.

Authors:  Zhenhua Liu; Yisen Meng; Yudong Cao; Yuke Chen; Yu Fan; Shaobo Li; Qun He; Shiliang Wu; Wei Yu; Jie Jin
Journal:  Transl Androl Urol       Date:  2020-04

5.  Diagnostic and Prognostic Implications of FGFR3high/Ki67high Papillary Bladder Cancers.

Authors:  Mirja Geelvink; Armin Babmorad; Angela Maurer; Robert Stöhr; Tobias Grimm; Christian Bach; Ruth Knuechel; Michael Rose; Nadine T Gaisa
Journal:  Int J Mol Sci       Date:  2018-08-28       Impact factor: 5.923

6.  SWI/SNF Alterations in Squamous Bladder Cancers.

Authors:  Fabian Achenbach; Michael Rose; Nadina Ortiz-Brüchle; Lancelot Seillier; Ruth Knüchel; Veronika Weyerer; Arndt Hartmann; Ronja Morsch; Angela Maurer; Thorsten H Ecke; Stefan Garczyk; Nadine T Gaisa
Journal:  Genes (Basel)       Date:  2020-11-19       Impact factor: 4.096

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.